Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitoxantrone tracer in thyroid cancer surgery
ChiCTR2300073612Phase 4Not yet recruiting
- Sponsor
- Hunan Cancer Hospital
- Start
- Jul 2023
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of mitoxantrone in thyroid cancer (4 arms), sponsored by Hunan Cancer Hospital. Primary endpoints: Lymph tracing rate, Rate of improper parathyroidectomy and 2 more. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
mitoxantrone
03
Conditions
thyroid cancer
Beyond the preview
Go deeper on ChiCTR2300073612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073612.